BRITTANY WHEATLEY: Open Payments
NPI 1679122790 · WATKINSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$824 in 35 payments from 9 companies in 2025. Trend: 2023 $674 · 2024 $418 · 2025 $824
Food & beverage: $824
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $379 |
| GENZYME CORPORATION | 8 | $252 |
| UCB, Inc. | 2 | $47 |
| Incyte Corporation | 2 | $40 |
| PFIZER INC. | 2 | $35 |
| Lilly USA, LLC | 1 | $23 |
| Galderma Laboratories, L.P. | 1 | $19 |
| Organogenesis Inc. | 1 | $15 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $14 |
Products named: BOTOX, DUPIXENT, SKYRIZI, Bimzelx, OPZELURA, CIBINQO, TALTZ, RINVOQ.
Industry payments across GA — which companies pay providers there.
